Experts are rapidly focused on retatrutide, a novel treatment created by Eli Lilly, as a significant breakthrough in body loss . Different than many existing approaches, retatrutide is a dual -action compound targeting simultaneously GLP-1 and GIP, hormones that affect satiety and blood glucose